Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $847.33 | 69 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Supernus Pharmaceuticals, Inc. | $149.20 | 9 | $0 (2021) |
| Takeda Pharmaceuticals U.S.A., Inc. | $99.93 | 24 | $0 (2018) |
| AstraZeneca Pharmaceuticals LP | $75.42 | 5 | $0 (2018) |
| Novartis Pharmaceuticals Corporation | $70.33 | 4 | $0 (2018) |
| Janssen Pharmaceuticals, Inc | $69.40 | 3 | $0 (2018) |
| Merck Sharp & Dohme Corporation | $55.22 | 4 | $0 (2018) |
| SANOFI-AVENTIS U.S. LLC | $51.06 | 3 | $0 (2018) |
| Daiichi Sankyo Inc. | $46.47 | 2 | $0 (2018) |
| Astellas Pharma US Inc | $36.76 | 2 | $0 (2018) |
| Lilly USA, LLC | $32.43 | 2 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $15.23 | 1 | Supernus Pharmaceuticals, Inc. ($15.23) |
| 2020 | $11.76 | 1 | Supernus Pharmaceuticals, Inc. ($11.76) |
| 2019 | $80.29 | 4 | Supernus Pharmaceuticals, Inc. ($80.29) |
| 2018 | $467.52 | 46 | Takeda Pharmaceuticals U.S.A., Inc. ($99.93) |
| 2017 | $272.53 | 17 | Janssen Pharmaceuticals, Inc ($45.78) |
All Payment Transactions
69 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/09/2021 | Supernus Pharmaceuticals, Inc. | TROKENDI XR (Drug) | Food and Beverage | Cash or cash equivalent | $15.23 | General |
| Category: AED | ||||||
| 01/24/2020 | Supernus Pharmaceuticals, Inc. | TROKENDI XR (Drug) | Food and Beverage | Cash or cash equivalent | $11.76 | General |
| Category: AED | ||||||
| 04/19/2019 | Supernus Pharmaceuticals, Inc. | TROKENDI XR (Drug) | Food and Beverage | Cash or cash equivalent | $22.38 | General |
| Category: AED | ||||||
| 03/08/2019 | Supernus Pharmaceuticals, Inc. | TROKENDI XR (Drug) | Food and Beverage | Cash or cash equivalent | $20.66 | General |
| Category: AED | ||||||
| 01/25/2019 | Supernus Pharmaceuticals, Inc. | TROKENDI XR (Drug) | Food and Beverage | Cash or cash equivalent | $19.30 | General |
| Category: AED | ||||||
| 01/04/2019 | Supernus Pharmaceuticals, Inc. | TROKENDI XR (Drug) | Food and Beverage | Cash or cash equivalent | $17.95 | General |
| Category: AED | ||||||
| 11/29/2018 | Takeda Pharmaceuticals U.S.A., Inc. | Trintellix (Drug) | Food and Beverage | In-kind items and services | $13.37 | General |
| Category: Central Nervous System (CNS) | ||||||
| 11/29/2018 | Takeda Pharmaceuticals U.S.A., Inc. | Trintellix (Drug) | Food and Beverage | In-kind items and services | $0.18 | General |
| Category: Central Nervous System (CNS) | ||||||
| 11/27/2018 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.05 | General |
| Category: NEUROSCIENCE | ||||||
| 11/16/2018 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.73 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/15/2018 | Merck Sharp & Dohme Corporation | STEGLATRO (Drug) | Food and Beverage | In-kind items and services | $18.91 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/01/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $23.62 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/04/2018 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $19.17 | General |
| Category: UROLOGY | ||||||
| 10/02/2018 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.72 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/21/2018 | Supernus Pharmaceuticals, Inc. | TROKENDI XR (Drug) | Food and Beverage | Cash or cash equivalent | $11.06 | General |
| Category: AED | ||||||
| 09/20/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $11.48 | General |
| Category: DIABETES | ||||||
| 09/18/2018 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | LUCEMYRA (Drug), RELISTOR, RELISTOR ORAL | Food and Beverage | In-kind items and services | $14.48 | General |
| Category: PAIN MEDICINE | ||||||
| 09/13/2018 | Ferring Pharmaceuticals Inc. | EUFLEXXA (Device) | Food and Beverage | In-kind items and services | $24.14 | General |
| Category: ORTHOPEDICS | ||||||
| 08/07/2018 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.33 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/19/2018 | Novo Nordisk Inc | Victoza (Drug), Tresiba, Xultophy 100/3.6 | Food and Beverage | In-kind items and services | $16.64 | General |
| Category: Diabetes | ||||||
| 06/20/2018 | Takeda Pharmaceuticals U.S.A., Inc. | Trintellix (Drug) | Food and Beverage | In-kind items and services | $8.61 | General |
| Category: Central Nervous System (CNS) | ||||||
| 06/20/2018 | Takeda Pharmaceuticals U.S.A., Inc. | Trintellix (Drug) | Food and Beverage | In-kind items and services | $2.75 | General |
| Category: Central Nervous System (CNS) | ||||||
| 06/20/2018 | Takeda Pharmaceuticals U.S.A., Inc. | Trintellix (Drug) | Food and Beverage | In-kind items and services | $0.78 | General |
| Category: Central Nervous System (CNS) | ||||||
| 06/06/2018 | Takeda Pharmaceuticals U.S.A., Inc. | Trintellix (Drug) | Food and Beverage | In-kind items and services | $8.25 | General |
| Category: Central Nervous System (CNS) | ||||||
| 06/06/2018 | Takeda Pharmaceuticals U.S.A., Inc. | Dexilant (Drug) | Food and Beverage | In-kind items and services | $0.20 | General |
| Category: Upper GI | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 473 | 849 | $297,845 | $65,913 |
| 2022 | 8 | 535 | 1,101 | $356,782 | $78,228 |
| 2021 | 13 | 544 | 1,085 | $301,237 | $73,019 |
| 2020 | 10 | 375 | 690 | $187,188 | $41,153 |
All Medicare Procedures & Services
39 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 225 | 482 | $188,810 | $38,427 | 20.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 151 | 151 | $59,230 | $18,650 | 31.5% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 12 | 12 | $10,555 | $3,375 | 32.0% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 18 | 40 | $24,822 | $2,033 | 8.2% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 11 | 11 | $6,490 | $1,733 | 26.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 22 | 23 | $5,980 | $1,359 | 22.7% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 13 | 13 | $272.00 | $254.41 | 93.5% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 21 | 117 | $1,686 | $81.07 | 4.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 246 | 603 | $228,690 | $47,228 | 20.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 134 | 134 | $50,886 | $16,746 | 32.9% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 43 | 43 | $24,911 | $6,757 | 27.1% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2022 | 23 | 56 | $32,661 | $2,858 | 8.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 34 | 43 | $10,972 | $2,374 | 21.6% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2022 | 12 | 12 | $5,722 | $1,929 | 33.7% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 13 | 13 | $182.00 | $179.76 | 98.8% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2022 | 30 | 197 | $2,758 | $156.02 | 5.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 188 | 545 | $200,915 | $45,557 | 22.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 103 | 103 | $37,961 | $13,225 | 34.8% |
| 20610 | Aspiration and/or injection of large joint or joint capsule | Office | 2021 | 25 | 64 | $31,258 | $3,104 | 9.9% |
| 90732 | Vaccine for pneumococcal polysaccharide for injection beneath the skin or into muscle, patient 2 years or older | Office | 2021 | 20 | 20 | $2,160 | $2,160 | 100.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 30 | 35 | $8,708 | $1,939 | 22.3% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 31 | 31 | $1,798 | $1,798 | 100.0% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 11 | 12 | $5,940 | $1,686 | 28.4% |
| 0003A | Fee covid-19 vac 1 booster | Office | 2021 | 28 | 28 | $1,680 | $1,068 | 63.6% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 12 | 12 | $6,791 | $973.03 | 14.3% |
About Dr. Mark Bradley, D.O
Dr. Mark Bradley, D.O is a Family Medicine healthcare provider based in Hartford, Wisconsin. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/01/2006. The National Provider Identifier (NPI) number assigned to this provider is 1427016575.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mark Bradley, D.O has received a total of $847.33 in payments from pharmaceutical and medical device companies, with $15.23 received in 2021. These payments were reported across 69 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($847.33).
As a Medicare-enrolled provider, Bradley has provided services to 1,927 Medicare beneficiaries, totaling 3,725 services with total Medicare billing of $258,313. Data is available for 4 years (2020–2023), covering 39 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Hartford, WI
- Active Since 05/01/2006
- Last Updated 02/07/2019
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1427016575
Products in Payments
- TROKENDI XR (Drug) $135.23
- Trintellix (Drug) $75.43
- FARXIGA (Drug) $75.42
- XARELTO (Drug) $69.40
- ENTRESTO (Drug) $52.68
- MYRBETRIQ (Drug) $36.76
- SOLIQUA (Drug) $32.23
- Victoza (Drug) $31.11
- Nucynta (Drug) $28.24
- Dexilant (Drug) $24.50
- EUFLEXXA (Device) $24.14
- INJECTAFER (Drug) $24.12
- Morphabond ER (Drug) $22.35
- STEGLATRO (Drug) $18.91
- PRALUENT (Drug) $18.83
- XOLAIR (Biological) $17.65
- TRULICITY (Drug) $17.32
- HUMALOG (Drug) $15.11
- LUCEMYRA (Drug) $14.48
- ASMANEX (Drug) $13.16
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Hartford
Mohammad Samer Younes, M.d, M.D
Family Medicine — Payments: $16,845
Mark Belsky, Md, MD
Family Medicine — Payments: $7,778
Dr. Nieves Hornbeck, M.d, M.D
Family Medicine — Payments: $7,619
Charlecinth Roberts, Md, MD
Family Medicine — Payments: $7,389
Susan Wiskowski, Md, MD
Family Medicine — Payments: $4,449
Sama Alvi, M.d, M.D
Family Medicine — Payments: $4,362